New rapid STI test aims to cut treatment wait times
NCT ID NCT07399873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether a fast, point-of-care test for chlamydia and gonorrhea can reduce the time it takes for people to start antibiotics. Four hundred asymptomatic adults visiting a sexual health clinic will be randomly assigned to receive either the rapid test or a standard lab test. Researchers will measure how quickly treatment begins and how many people complete treatment within a week.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Point-of-care diagnostic test (Cobas Liat CT/NG Assay and CRISPR-based assay)
- What this could lead to
- If successful, this could make STI testing much faster, allowing people to get treated sooner and reducing the spread of infections.
- What could go wrong
- This is an early-stage trial focused on speed of treatment, not on curing or preventing disease. The new tests may not be as accurate as standard lab tests, and results may not apply to people with symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 400 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * At least 18 years of age * Willing and able to provide informed consent * Asymptomatic at the urogenital site * Being screened for urogenital C. trachomatis and/or N. gonorrhoeae as part of routine clinical care Exclusion Criteria: * Indication for antimicrobial therapy for C. trachomatis or N. gonorrhoeae at the time of the visit, regardless of test results
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chlamydia trachomatis infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.